These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [An evaluation of pathologic T3 lung cancer].
    Author: Miyazawa M, Yamanda T, Aoki T, Kaneko K, Yoshida K, Hanaoka T, Machida E, Takasuna K, Kondo R, Numanami H, Haniuda M, Amano J.
    Journal: Kyobu Geka; 1998 Oct; 51(11):930-4. PubMed ID: 9789422.
    Abstract:
    A total of 35 pT3 patients of lung cancer underwent pulmonary resection from 1983 to 1997 in our department. The overall five-year survival rate of the 35 cases was 35.8%. There was no significant difference between the five-year survival rate of squamous cell carcinoma and that of adenocarcinoma. A superior outcome was observed for cases of curative resection compared with that of non-curative resection. Five-year survival rates of 19 patients with N0 disease, 16 patients with N1 or N2 disease were 46.6% and 22.2% respectively (p < 0.05). There was no significant differences among the survival rates according to the site of tumor invasion. We concluded that the long-term survival of patients with pathologic T3 disease critically depended on the lymph node state and completeness of resection.
    [Abstract] [Full Text] [Related] [New Search]